Signity Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Nagpur, Maharashtra, India, established in 2010.
2010 Nagpur, Maharashtra, India Active
Last Updated:
Access Report
About Signity Pharmaceuticals Private Limited

Signity Pharmaceuticals Private Limited, a active private limited company, was established on 13 September 2010 in Nagpur, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U74900MH2010PTC207591. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹6.49 M.

It upholds a compliant status. Employing 45 professional, Its leadership includes Bhupendra Bhaskar Marliwar (Director), Saiye Bhupendra Marliwar (Additional Director), Bhraman Bhaskar Marliwar (Additional Director). Past directors included Samir Deodatta Sawwalakhe, Vishalkumar Sunderlal Mulani, Shridhar Diwakar Dhavle. It holds ₹4.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.10, Ground Floor , Dnyanyog Apartment, Deo Nagar, Khamla Road, Nagpur, Maharashtra, 440015.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74900MH2010PTC207591

  • Registration Number

    207591

  • Incorporation Date

    13 September 2010

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹6.49 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 6.49 M
  • Company Age 15 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.00 Cr
  • Revenue Growth **** 16.43%
  • Profit Growth **** 2.11%
  • Ebitda **** -27.69%
  • Net Worth 20.86%
  • Total Assets **** 24.51%
Company report

Signity Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Signity Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Signity Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Bhupendra Bhaskar Marliwar Director 13 Sep 2010 Current
Saiye Bhupendra Marliwar Additional Director 19 Jul 2025 Current
Bhraman Bhaskar Marliwar Additional Director 19 Jul 2025 Current
Bhushan Bhaskar Marliwar Additional Director 22 Aug 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 08 Jan 2015 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director - Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Signity Pharmaceuticals.

Signity Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.43% increase. The company also saw a slight improvement in profitability, with a 2.11% increase in profit. The company's net worth Soared by an impressive increase of 20.86%.

Signity Pharmaceuticals revenue growth over time
Signity Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 16.43%
*******
*******
*******
*******
Revenue from Operations
*******
 16.43%
*******
*******
*******
*******
Total Assets
*******
 24.51%
*******
*******
*******
*******
Profit or Loss
*******
 2.11%
*******
*******
*******
*******
Net Worth
*******
 20.86%
*******
*******
*******
*******
EBITDA
*******
 -27.69%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Signity Pharmaceuticals?

In 2023, Signity Pharmaceuticals had a public holding of 57.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹40,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Others : 4.00 Cr
Latest Charge Details
Date Lender Amount Status
11 Sep 2025 Others ₹4.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Signity Pharmaceuticals?

Signity Pharmaceuticals has a workforce of 45 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Signity Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Signity Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Signity Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Signity Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 4.00 Cr with Charge ID 101158725 was registered on 11 Sep 2025. was completed.

  • Charges

    Progress on A charge with Others of Rs. 4.00 Cr registered on 11 Sep 2025 with Charge ID 101158725 was modified on 11 Sep 2025. was documented.

  • Director Appointment

    The activity Bhushan Bhaskar Marliwar was appointed as a Additional Director was appointed as a Additional Director on 22 Aug 2025 & has been associated with this company since 6 months 21 days . was completed.

  • Director Appointment

    Saiye Bhupendra Marliwar was appointed as a Additional Director was appointed as a Additional Director on 19 Jul 2025 & has been associated with this company since 7 months 24 days . was recorded as a recent event.

  • Director Appointment

    The activity Bhraman Bhaskar Marliwar was appointed as a Additional Director was appointed as a Additional Director on 19 Jul 2025 & has been associated with this company since 7 months 24 days . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Signity Pharmaceuticals Private Limited?

The CIN of Signity Pharmaceuticals Private Limited is U74900MH2010PTC207591.

Where is Signity Pharmaceuticals Private Limited headquartered?

Signity Pharmaceuticals Private Limited is headquartered at Plot No.10, Ground Floor , Dnyanyog Apartment, Deo Nagar, Khamla Road, Nagpur, Maharashtra, 440015.

When was Signity Pharmaceuticals Private Limited incorporated?

Signity Pharmaceuticals Private Limited was incorporated on 13 September 2010.

Who are the current directors of Signity Pharmaceuticals Private Limited?

The current directors of Signity Pharmaceuticals Private Limited are

What is the primary industry of Signity Pharmaceuticals Private Limited?

The primary industry of Signity Pharmaceuticals Private Limited is Trade.

Is Signity Pharmaceuticals Private Limited a listed company?

Signity Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Signity Pharmaceuticals Private Limited?

The authorized capital of Signity Pharmaceuticals Private Limited is ₹2.00 Cr, and the paid-up capital is ₹6.49 M.

What is the compliance status of Signity Pharmaceuticals Private Limited?

The compliance status of Signity Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available